Reinforced Pancreaticojejunostomy With or Without glubran2

Launched by MINIA UNIVERSITY · Dec 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a surgical technique called reinforced pancreaticojejunostomy with or without a special tissue glue called Glubran2. The goal is to find out which method works best to prevent a serious complication known as pancreatic fistula that can occur after surgery for pancreatic cancer. By comparing these two techniques, the researchers hope to improve long-term health outcomes for patients undergoing surgery for pancreatic or periampullary cancers.

To be eligible for this study, participants must be adults aged 65 to 75 who are scheduled for surgery to remove cancer from the pancreas and can provide informed consent to join the trial. Unfortunately, those who are too ill for surgery, have tumors that cannot be removed, or have cancer that has spread to other parts of the body cannot take part. If you decide to participate, you can expect to receive careful monitoring during and after your surgery to evaluate the effectiveness of these techniques in preventing complications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All the patients undergoing pancreaticoduodenectomy for cancer
• • Patients able to give their informed consent
• Exclusion Criteria:
• • Unfit patients for surgery due to severe medical illness.
• • Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
• • Presence of distant metastasis .
• • Patients refused to participate in the study.